{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:48:41Z","timestamp":1777042121621,"version":"3.51.4"},"reference-count":0,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"4","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Noncommunicable diseases disproportionately affect low- and middle-income countries, which are projected to account for 75% of global cancer deaths by 2030. Latin America faces unique challenges, including fragmented health systems, limited infrastructure, and significant inequities in access to screening and innovative therapies. This special series in\n                      <jats:italic toggle=\"yes\">JCO Global Oncology<\/jats:italic>\n                      highlights context-specific research from Latin American experts designed to bridge evidence gaps and strengthen regional oncology practice. Key Themes and Findings: Digital Innovation: Studies explore telehealth to expand supportive care in remote areas and online platforms to address the shortage of geriatric oncology specialists. Precision Medicine: Research emphasizes the need for region-specific genomic data, noting that hereditary cancer patterns in Latin America differ from those in the Global North. While molecular profiling (eg, for \u201cEGFR\u201d and \u201cALK\u201d in lung cancer) significantly improves survival, access to testing remains a major barrier. Health Economics: A budget impact analysis suggests that prioritizing cost-effective surgical castration over medical alternatives could save over $600 million US dollars, allowing for reinvestment in advanced therapies. Real-World Evidence: Data on genitourinary cancers and rare soft tissue sarcomas reveal persistent disparities in treatment patterns and emphasize the necessity of multidisciplinary care. Moving forward, the region must transition from retrospective data to prospective, interventional studies. Addressing the \u201cimplementation gap\u201d\u2014where diagnostics exist without matching treatment access\u2014is vital. Sustained progress requires locally adapted guidelines, improved registries, and increased research funding to ensure equitable, high-quality cancer care across Latin America.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"go-26-00150fu1.tif\"\/>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-26-00150","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:59:12Z","timestamp":1776974352000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Latin America Special Series Infographic"],"prefix":"10.1200","volume":"12","author":[{"given":"Maria T.","family":"Bourlon","sequence":"first","affiliation":[{"name":"Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico"},{"name":"Universidad Panamericana, Escuela de Medicina, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Kihn-Alarc\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Research, Liga Nacional Contra el C\u00e1ncer &amp; Instituto de Cancerolog\u00eda, Guatemala City, Guatemala"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-4395","authenticated-orcid":true,"given":"Paola I.","family":"Valdez-Sandoval","sequence":"additional","affiliation":[{"name":"Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-26-00150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:51:59Z","timestamp":1777035119000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-26-00150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1200\/GO-26-00150"],"URL":"https:\/\/doi.org\/10.1200\/go-26-00150","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2600150"}}